The Indian stock market kicked off trading today, April 15, 2025, with an energetic bounce back after a long weekend and a three-week period of low activity. This revival comes amidst significant sector developments, the beginning of the much-anticipated earnings season, and a surprising tariff announcement from US President Donald Trump that has stirred global markets. Let’s dive into the key stocks making headlines today.
Market Overview on April 15, 2025
Last Friday, April 11, Indian stock indices finished the week on a strong note, reflecting a broad-based rally. The Sensex soared by 1,310 points (1.77%), closing at 75,157.26, while the Nifty climbed 429 points (1.92%), ending at 22,828.55. This robust performance has set an optimistic tone as trading resumes.
Key Stocks in Focus
Macrotech Developers
The Lodha brothers, Abhishek and Abhinandan, have put an end to their long-standing brand name dispute. Moving forward, Abhishek Lodha, who leads Macrotech Developers, will retain exclusive rights to the ‘Lodha’ and ‘Lodha Group’ brand names, while Abhinandan Lodha will keep his own brand, House of Abhinandan Lodha (HoABL).
Dr. Reddy’s Laboratories
This week, Dr. Reddy’s Laboratories faced rumors about potential layoffs, with reports suggesting a 25% cut in employee-related costs. However, the pharmaceutical company refuted these claims, labeling the report as “factually incorrect” in a formal communication to the stock exchange.
Reliance Industries
Mukesh Ambani’s Reliance Industries is gradually expanding its presence in the shipping sector by acquiring an additional 10% stake in Nauyaan Shipyard Private Ltd. This investment, amounting to Rs 1.72 crore, signifies a deeper commitment to diversifying its business portfolio.
Vedanta
Vedanta is currently under scrutiny in Odisha, where the state’s Pollution Control Board has imposed a penalty of Rs 71.16 crore for alleged mismanagement of fly ash. The company has contested these charges, asserting that the penalty fails to acknowledge its compliance history and plans to take legal action.
Zydus Lifesciences
In a positive development, Zydus Lifesciences has secured final approval from the USFDA to market Jaythari (Deflazacort) Tablets in the United States. This medication is aimed at treating Duchenne muscular dystrophy (DMD), a rare condition affecting muscle strength, particularly in children. The firm can now launch a generic version of Emflaza in four different strengths.
State Bank of India (SBI)
Following the RBI’s recent policy rate reduction, the State Bank of India announced a 25 basis points cut in its Repo Linked Lending Rate (RLLR), bringing it down to 8.25%. This move is expected to enhance lending opportunities in the market.
Delhivery
In a noteworthy change, Sahil Barua, co-founder and CEO of logistics leader Delhivery, has stepped down from the board of Swiggy. His exit, formally noted on April 11, represents a subtle shift in Swiggy’s leadership dynamics, even as Barua continues to lead Delhivery.
JK Cement
JK Cement is exploring the option of raising Rs 500 crore through the private placement of non-convertible debentures (NCDs). The board is set to convene on May 24 to deliberate on this fundraising strategy, which will be presented to shareholders during the upcoming 31st annual general meeting.
Persistent Systems
In corporate news, Persistent Systems is merging its wholly-owned subsidiary, Capiot Software, into the parent company, following recent approval from the National Company Law Tribunal (NCLT).
HCL Tech
On the technology front, HCL Tech continues to make strides, recently earning three new specializations as a Google Cloud Partner in areas such as generative AI services, cloud migration, and infrastructure modernization.
With a mix of positive developments and challenges, today’s market activity promises to keep investors on their toes.
